Filing Details

Accession Number:
0001735276-24-000070
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-26 16:28:27
Reporting Period:
2024-06-24
Accepted Time:
2024-06-26 16:28:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178670 Alnylam Pharmaceuticals Inc. ALNY () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1051578 I E David Pyott 675 West Kendall Street
Henri A. Termeer Square
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-06-24 17,560 $88.95 17,696 No 4 M Direct
Common Stock Acquisiton 2024-06-24 7,420 $70.20 25,116 No 4 M Direct
Common Stock Acquisiton 2024-06-24 7,470 $71.99 32,586 No 4 M Direct
Common Stock Disposition 2024-06-24 17,560 $220.00 15,026 No 4 S Direct
Common Stock Disposition 2024-06-24 7,420 $221.00 7,606 No 4 S Direct
Common Stock Disposition 2024-06-24 7,470 $222.00 136 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2024-06-24 7,420 $0.00 7,420 $70.20
Common Stock Stock Option (right to buy) Disposition 2024-06-24 7,470 $0.00 7,470 $71.99
Common Stock Stock Option (right to buy) Disposition 2024-06-24 17,560 $0.00 17,560 $88.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,830 2017-06-03 2026-06-03 No 4 M Direct
3,780 2018-06-02 2027-06-01 No 4 M Direct
7,440 2025-12-18 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 27,900 Indirect by Trust
Footnotes
  1. The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on August 11, 2023.
  2. The shares of ALNY common stock were purchased by the David E I Pyott Trust, of which the reporting person is trustee.
  3. This stock option was fully vested and exercisable as of June 3, 2017.
  4. This stock option was fully vested and exercisable as of June 2, 2018.
  5. This stock option was fully vested and exercisable as of December 18, 2018.